Austrália - inglês - Department of Health (Therapeutic Goods Administration)

juno pharmaceuticals pty ltd - suxamethonium chloride -

Austrália - inglês - Department of Health (Therapeutic Goods Administration)

juno pharmaceuticals pty ltd - pancuronium bromide, quantity: 2 mg/ml - injection, solution - excipient ingredients: water for injections; sodium acetate; sodium chloride; acetic acid; sodium hydroxide - indiactions as at 1 january 1991: 1. as an adjunct to surgical anaesthesia to induce skeletal muscle relaxation to facilitate operative manipulations. the necessary conditions for intubation can be achieved with pancuronium bromide alone or following suxamethonium. 2. pancuronium bromide is also indicated to promote mechanical ventilation by reducing or eliminating spontaneous breathing effort in intensive care patients.

Austrália - inglês - Department of Health (Therapeutic Goods Administration)

astrazeneca pty ltd - water for injections -

Austrália - inglês - Department of Health (Therapeutic Goods Administration)

astrazeneca pty ltd - terbutaline sulfate, quantity: 0.5 mg/ml - injection, solution - excipient ingredients: hydrochloric acid; sodium chloride; water for injections - indications ast at 24 june 2004: for relief of bronchospasm in patients with asthma or chronic obstructive pulmonary disease, and for acute prophylaxis against exercise-induced asthma or in other situations known to induce bronchospasm. bricanyl injection: bricanyl injection solution is recommended for acute use only.

Austrália - inglês - Department of Health (Therapeutic Goods Administration)

astrazeneca pty ltd - formoterol fumarate dihydrate, quantity: 4.5 microgram/actuation - inhalation, powder for - excipient ingredients: lactose monohydrate - long-term treatment of reversible airways obstruction in asthma (including nocturnal asthma and exercise induced asthma) in adults and children aged 12 years and over and who are receiving inhaled or oral corticosteroids and who require bronchodilator therapy.,oxis turbuhaler can be used on demand (prn) in asthmatics over the age of 18 years who are receiving inhaled or oral corticosteroids. it should not be used in patients whose asthma can be managed alone by occasional use of short acting inhaled beta-2 agonists.

Austrália - inglês - Department of Health (Therapeutic Goods Administration)

astrazeneca pty ltd - formoterol fumarate dihydrate, quantity: 9 microgram/actuation - inhalation, powder for - excipient ingredients: lactose monohydrate - long-term treatment of reversible airways obstruction in asthma (including nocturnal asthma and exercise induced asthma) in adults and children aged 12 years and over and who are receiving inhaled or oral corticosteroids and who require bronchodilator therapy.,oxis turbuhaler can be used on demand (prn) in asthmatics over the age of 18 years who are receiving inhaled or oral corticosteroids. it should not be used in patients whose asthma can be managed alone by occasional use of short acting inhaled beta-2 agonists.

Austrália - inglês - Department of Health (Therapeutic Goods Administration)

astrazeneca pty ltd - terbutaline sulfate, quantity: 400 microgram/actuation - inhalation, powder for - excipient ingredients: lactose monohydrate - for relief of bronchospasm in patients with asthma or chronic obstructive pulmonary disease, and for acute prophylaxis against exercise-induced asthma or in other situations known to induce bronchospasm.,bricanyl turbuhaler is intended for short-term management of bronchospasm.

Austrália - inglês - Department of Health (Therapeutic Goods Administration)

astrazeneca pty ltd - felodipine, quantity: 10 mg - tablet, modified release - excipient ingredients: sodium stearylfumarate; carnauba wax; hypromellose; aluminium sodium silicate; iron oxide red; titanium dioxide; hyprolose; lactose; iron oxide yellow; peg-40 hydrogenated castor oil; microcrystalline cellulose; macrogol 6000; propyl gallate - hypertension.

Austrália - inglês - Department of Health (Therapeutic Goods Administration)

astrazeneca pty ltd - felodipine, quantity: 5 mg - tablet, modified release - excipient ingredients: aluminium sodium silicate; sodium stearylfumarate; propyl gallate; lactose; hyprolose; titanium dioxide; hypromellose; iron oxide yellow; microcrystalline cellulose; iron oxide red; carnauba wax; peg-40 hydrogenated castor oil; macrogol 6000 - hypertension.

Austrália - inglês - Department of Health (Therapeutic Goods Administration)

astrazeneca pty ltd - felodipine, quantity: 2.5 mg - tablet, modified release - excipient ingredients: hypromellose; iron oxide yellow; lactose; aluminium sodium silicate; macrogol 6000; propyl gallate; titanium dioxide; microcrystalline cellulose; sodium stearylfumarate; hyprolose; peg-40 hydrogenated castor oil; carnauba wax - hypertension.